Investor Presentation Q1 2018 Audited Results
IV Appendix
Balance Sheet
In EGP
2014
2015
2016
2017
1Q2017
1Q2018
Property & Equipment, net
118,666
152,479
171,327
210,264
180,215
221,731
Other Assets
2,840
5,307
6,667
8,804
6,481
8,804
Project Under Construction
25,864
13,787
47,639
161,267
111,402
276,755
Deferred Income Taxes
3,876
6,911
11,704
11,104
11,704
11,400
Total Long Term Assets
151,246
178,485
237,336
391,438
309,802
518,637
Inventories
427,320
455,770
611,993
1,050,549
774,600
Incoming Documents for Collection
316
442
2,357
273
1,527
971,748
527.517661
Trade & Notes receivable, net
Supplier Advances
1,127,421
12,576
1,379,307
1,946,304
2,459,296
1,982,090
2,706,771
30,652
59,951
101,360
218,127
201,573
Debtors & Other Debit Balance, net
90,029
135,714
153,602
165,718
164,377
131,417
Due from Related Parties
371
371
372
372
371
Cash & Cash Equivalent
16,368
32,866
43,880
164,791
39,134
Total Current Assets
1,674,402
2,035,123
2,818,459
3,942,358
3,180,228
372
41,718
4,054,128
Total Assets
Paid In Capital
Share Premium
General Reserve
1,825,648
2,213,607
3,055,796
4,333,796
3,490,031
4,572,765
20,000
24,000
24,000
168,000
24,000
180,500
0
148,000
0
0
0
277500
0
0
147,079
3,079
147,079
3,079
Legal Reserve
6,334
8,211
12,000
12,000
12,000
20,507
Retained Earnings
46,255
13,000
26,944
62,980
122,785
224,610
Net Profit For The Year
37,541
57,358
101,748
170,137
28,870
27,954
Total Shareholders' Equity
110,131
250,570
311,771
416,196
334,735
734,150
Non-current portion of medium term loan
21,978
14,768
29,632
25,083
33,636
59,339
Non-current notes payable
23,880
35,861
20,312
7,660
13,887
6,090
Other Non-current liabilities
0
0
11,251
20,815
11,251
24,939
Non-current portion of land creditors
212
141
71
0
71
0
Total Long-term Liabilities
46,070
50,771
61,266
53,559
58,845
90,368
Credit facilities
Contingency provision
206,501
156,686
68,644
6,952
409,350
93,711
0
600
3,100
24,067
2,067
27,567
Customers Advance Payments
4,757
6,003
6,324
6,453
10,214
5,178
Current portion of land creditors
401
1,001
101
71
Trade and notes payable
1,389,370
1,678,860
2,519,985
3,700,786
101
2,622,246
Current portion of medium term loan
25,212
24,866
13,112
25,794
13,733
71
3,523,678
30,496
Creditors & other credit balances
43,206
44,251
71,492
99,919
38,740
67,545
Total Current Liabilities
1,669,447
1,912,267
2,682,759
3,864,041
3,096,451
Total Liabilities & Shareholders Equity
1,825,648
2,213,607
3,055,796
4,333,796
3,490,031
3,748,247
4,572,765
ibnsinapharma
Source: Company Management
28View entire presentation